Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID)-Reference-Cited by-同舟云学术

Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID)

Published:2011 Issue:3 Volume:13 Page:R75
ISSN:1478-6354
Container-title:Arthritis Research & Therapy
language:en
Short-container-title:Arthritis Res Ther

Author:

Tony Hans-Peter,Burmester Gerd,Schulze-Koops Hendrik,Grunke Mathias,Henes Joerg,Kötter Ina,Haas Judith,Unger Leonore,Lovric Svjetlana,Haubitz Marion,Fischer-Betz Rebecca,Chehab Gamal,Rubbert-Roth Andrea,Specker Christof,Weinerth Jutta,Holle Julia,Müller-Ladner Ulf,König Ramona,Fiehn Christoph,Burgwinkel Philip,Budde Klemens,Sörensen Helmut,Meurer Michael,Aringer Martin,Kieseier Bernd,Erfurt-Berge Cornelia,Sticherling Michael,Veelken Roland,Ziemann Ulf,Strutz Frank,von Wussow Praxis,Meier Florian MP,Hunzelmann Nico,Schmidt Enno,Bergner Raoul,Schwarting Andreas,Eming Rüdiger,Hertl Michael,Stadler Rudolf,Schwarz-Eywill Michael,Wassenberg Siegfried,Fleck Martin,Metzler Claudia,Zettl Uwe,Westphal Jens,Heitmann Stefan,Herzog Anna L,Wiendl Heinz,Jakob Waltraud,Schmidt Enno,Freivogel Klaus,Dörner Thomas,

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy,Rheumatology

Reference58 articles.

1. The role of B cells in rheumatoid arthritis

2. B-cell targeting in rheumatoid arthritis and other autoimmune diseases

3. B cells as therapeutic targets in SLE

4. B-cell-directed therapies for autoimmune disease

5. Rituximab therapy and autoimmune disorders: Prospects for anti-B cell therapy

Cited by 172 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Future of CAR T Therapeutics to Treat Autoimmune Disorders;Molecular Diagnosis & Therapy;2024-07-30

2. Differences in risk of serious infections between patients with secondary versus primary nephropathy following rituximab treatment: a retrospective cohort study;Frontiers in Immunology;2024-06-11

3. Multiple Sclerosis, Rituximab, Hypogammaglobulinemia, and Risk of Infections;Neurology Neuroimmunology & Neuroinflammation;2024-05

4. Rituximab Use and the Increased Risk of Reactivation of Latent Tuberculosis?;Journal of Advanced Lung Health;2024-03-29

5. Infections and Behçet Disease;Infection and Autoimmunity;2024